Acrivon Therapeutics, Inc. Common Stock (ACRV) vs Conexeu Sciences Inc. (CNXU)

A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and Conexeu Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACRV

Acrivon Therapeutics, Inc. Common Stock

$83M

$1.94HealthcareDelayed quote: Oct 6, 2026, 12:19 PM EDT

CNXU

Conexeu Sciences Inc.

$98M

$3.67HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT

Total return — ACRV vs CNXU

growth of $100 · dividends reinvested · last 1y

ACRV +10.6% (+10.6%/yr)CNXU -76.1% (-76.1%/yr)ACRV compounded faster over this window

ACRV CNXU

Metrics side by side

Total return (annualized)

Metric	ACRV	CNXU
Total return (1Y)	3.65%	N/A
Total return CAGR (3Y)	-35.32%	N/A

CNXU is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full ACRV analysis Full CNXU analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.